Skip to main content

Urate crystal deposition, prevention and various diagnosis techniques of GOUT arthritis disease: a comprehensive review

Abstract

Gout is described as difficult in joint sore, uttermost ordinarily in the principal metatarsophalangeal joint, attend from formation of urate monosodium crystallization in a joint space. Analysis might be affirmed by recognizable proof of urate monosodium precious stones in synovial liquid of the influenced joint. There has been expanded enthusiasm for gout in common scholarly and clinical practice settings. The pervasiveness of both hyperuricemia and gout has ascended as most recent decade of time in created nations and in this way weight of gout as expanded. The relationship of hyperuricemia and gout with cardio results for chance of added advantages in mediation on hyperuricemia was featured in this audit. Imaging procedures have ended up being helpful for location of urate statement, even before the primary clinical indications, empowering the assessment of the degree of testimony and giving target estimation of precious stone exhaustion amid urate-bringing down treatment. In advancement, the indication defines the pre diagnostic of gout and associated commodities is advised to prevent the inflammation, that image procedures will assess the weight on statement as well reaction to urinary bringing down clinical procedure in chose patients, lastly amongst last key goal on social insurance for clinical evaluation with gout is to totally project urate gem stores. In spite of the fact that the formal determination is defined with arthrocentesis and resulting examination, CT and ultrasound discoveries on addition of evaluation and execution of infection administration. The standard therapy methodology is available for the patients and whose disease is refractory to standard therapy.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

References

  1. Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016;388(10055):2039–52.

    Article  Google Scholar 

  2. Emmerson BT. The management of gout. N Engl J Med. 1996;334(7):445–51.

    Article  Google Scholar 

  3. Pascual E, Sivera F. Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout. Ann Rheum Dis. 2007;66(8):1056–8.

    Article  Google Scholar 

  4. Singh JA. Challenges faced by patients in gout treatment: a qualitative study. J Clin Rheumatol. 2014;20(3):172–4.

    Article  Google Scholar 

  5. Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11(11):649–62.

    Article  Google Scholar 

  6. McCarty DJ, Hollander JL. Identification of urate crystals in gouty synovial fluid. Ann Intern Med. 1961;54:452–60.

    Article  Google Scholar 

  7. Mandal AK, Mount DB. The molecular physiology of uric acid homeostasis. Annu Rev Physiol. 2015;77:323–45.

    Article  Google Scholar 

  8. Kamei K, Konta T, Hirayama A, Suzuki K, Ichikawa K, Fujimoto S. A slight increase within the normal range of serum uric acid and the decline in renal function: associations in a community-based population. Nephrol Dial Transpl. 2014;29(12):2286–92.

    Article  Google Scholar 

  9. Torres RJ, Puig JG. Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J Rare Dis. 2007;2:48.

    Article  Google Scholar 

  10. Reginato AM, Olsen BR. Genetics and experimental models of crystal-induced arthritis. Lessons learned from mice and men: is it crystal clear? Curr Opin Rheumatol. 2007;19(2):134–45.

    Article  Google Scholar 

  11. Kanbara A, Seyama I. Effect of urine pH on uric acid excretion by manipulating food materials. Nucleosides Nucleotides Nucleic Acids. 2011;30(12):1066–71.

    Article  Google Scholar 

  12. Towiwat P, Li ZG. The association of vitamin C, alcohol, coffee, tea, milk and yogurt with uric acid and gout. Int J Rheum Dis. 2015;18(5):495–501.

    Article  Google Scholar 

  13. Mahmoud HH, Leverger G, Patte C, Harvey E, Lascombes F. Advances in the management of malignancy-associated hyperuricaemia. Br J Cancer. 1998;77(Suppl 4):18–20.

    Article  Google Scholar 

  14. Emmerson B. Hyperlipidaemia in hyperuricaemia and gout. Ann Rheum Dis. 1998;57(9):509–10.

    Article  Google Scholar 

  15. Bedir A, Topbas M, Tanyeri F, Alvur M, Arik N. Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J. 2003;44(4):527–36.

    Article  Google Scholar 

  16. Dessein PH, Shipton EA, Stanwix AE, Joffe BI, Ramokgadi J. Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis. 2000;59(7):539–43.

    Article  Google Scholar 

  17. Ichida K, Matsuo H, Takada T, Nakayama A, Murakami K, Shimizu T. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun. 2012;3:764.

    Article  Google Scholar 

  18. Enomoto A, Endou H. Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease. Clin Exp Nephrol. 2005;9(3):195–205.

    Article  Google Scholar 

  19. Bobulescu IA, Moe OW. Renal transport of uric acid: evolving concepts and uncertainties. Adv Chronic Kidney Dis. 2012;19(6):358–71.

    Article  Google Scholar 

  20. Han J, Liu Y, Rao F, Nievergelt CM, O’Connor DT, Wang X. Common genetic variants of the human uromodulin gene regulate transcription and predict plasma uric acid levels. Kidney Int. 2013;83(4):733–40.

    Article  Google Scholar 

  21. Parthasarathy P, Vivekanandan S. A comprehensive review on thin film-based nano-biosensor for uric acid determination: arthritis diagnosis. World Rev Sci Technol Sustain Dev. 2018;14(1):52–71.

    Article  Google Scholar 

  22. Cho SK, Kim S, Chung JY, Jee SH. Discovery of URAT1 SNPs and association between serum uric acid levels and URAT1. BMJ Open. 2015;5(11):e009360.

    Article  Google Scholar 

  23. Tan PK, Ostertag TM, Miner JN. Mechanism of high affinity inhibition of the human urate transporter URAT1. Sci Rep. 2016;6:34995.

    Article  Google Scholar 

  24. Phipps-Green AJ, Merriman ME, Topless R, Altaf S, Montgomery GW, Franklin C. Twenty-eight loci that influence serum urate levels: analysis of association with gout. Ann Rheum Dis. 2016;75(1):124–30.

    Article  Google Scholar 

  25. Parthasarathy P, Vivekanandan S. A numerical modelling of an amperometric-enzymatic based uric acid biosensor for GOUT arthritis diseases. Inform Med Unlocked. 2018. https://doi.org/10.1016/j.imu.2018.03.001.

    Article  Google Scholar 

  26. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 2009;5(6):e1000504.

    Article  Google Scholar 

  27. Liu R, O’Connell M, Johnson K, Pritzker K, Mackman N, Terkeltaub R. Extracellular signal-regulated kinase 1/extracellular signal-regulated kinase 2 mitogen-activated protein kinase signaling and activation of activator protein 1 and nuclear factor kappaB transcription factors play central roles in interleukin-8 expression stimulated by monosodium urate monohydrate and calcium pyrophosphate crystals in monocytic cells. Arthritis Rheum. 2000;43(5):1145–55.

    Article  Google Scholar 

  28. Cronstein BN, Sunkureddi P. Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis. J Clin Rheumatol. 2013;19(1):19–29.

    Google Scholar 

  29. Parthasarathy P, Vivekanandan S. Investigation on uric acid biosensor model for enzyme layer thickness for the application of arthritis disease diagnosis. Health Inf Sci Syst. 2018;6:1–6.

    Google Scholar 

  30. Busso N, Ea HK. The mechanisms of inflammation in gout and pseudogout (CPP-induced arthritis). Reumatismo. 2012;63(4):230–7.

    Article  Google Scholar 

  31. Ea HK. Mechanisms of gout inflammation. Presse Med. 2011;40(9 Pt 1):836–43.

    Article  Google Scholar 

  32. Dalbeth N, Lauterio TJ, Wolfe HR. Mechanism of action of colchicine in the treatment of gout. Clin Ther. 2014;36(10):1465–79.

    Article  Google Scholar 

  33. Steiger S, Harper JL. Mechanisms of spontaneous resolution of acute gouty inflammation. Curr Rheumatol Rep. 2014;16(1):392.

    Article  Google Scholar 

  34. Nuki G, Simkin PA. A concise history of gout and hyperuricemia and their treatment. Arthr Res Ther. 2006;8(suppl 1):S1.

    Article  Google Scholar 

  35. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63(10):3136–41.

    Article  Google Scholar 

  36. Parthasarathy P, Vivekanandan S. A typical IoT architecture-based regular monitoring of arthritis disease using time wrapping algorithm. Int J Comput Appl. 2018. https://doi.org/10.1080/1206212X.2018.1457471.

    Article  Google Scholar 

  37. Dirken-Heukensfeldt KJ, Teunissen TA, van de Lisdonk H, Lagro-Janssen AL. Clinical features of women with gout arthritis. A systematic review. Clin Rheumatol. 2010;29(6):575–82.

    Article  Google Scholar 

  38. Reginato AM, Mount DB, Yang I, Choi HK. The genetics of hyperuricaemia and gout. Nat Rev Rheumatol. 2012;8(10):610–21.

    Article  Google Scholar 

  39. Yang Q, Köttgen A, Dehghan A, et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet. 2010;3(6):523–30.

    Article  Google Scholar 

  40. Mount DB. The kidney in hyperuricemia and gout. Curr Opin Nephrol Hypertens. 2013;22(2):216–23.

    Article  Google Scholar 

  41. Ning TC, Keenan RT. Unusual clinical presentations of gout. Curr Opin Rheumatol. 2010;22(2):181–7.

    Article  Google Scholar 

  42. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987;82(3):421–6.

    Article  Google Scholar 

  43. Schumacher HR Jr. The pathogenesis of gout. Clevel Clin J Med. 2008;75(suppl 5):S2–4.

    Article  Google Scholar 

  44. Roddy E, Zhang W, Doherty M. Are joints affected by gout also affected by osteoarthritis? Ann Rheum Dis. 2007;66(10):1374–7.

    Article  Google Scholar 

  45. Choi HK, Atkinson K, Karlson EW, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004;350(11):1093–103.

    Article  Google Scholar 

  46. Zhang Y, Neogi T, Chen C, et al. Cherry consumption and decreased risk of recurrent gout attacks. Arthritis Rheum. 2012;64(12):4004–11.

    Article  Google Scholar 

  47. Pillinger MH, Goldfarb DS, Keenan RT. Gout and its comorbidities. Bull NYU Hosp Jt Dis. 2010;68(3):199–203.

    Google Scholar 

  48. Agarwal V, Hans N, Messerli F. Effect of allopurinol on blood pressure: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2013;15(6):435–42.

    Article  Google Scholar 

  49. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54(8):2688–96.

    Article  Google Scholar 

  50. Schumacher HR Jr, Chen LX. Newer therapeutic approaches: gout. Rheum Dis Clin N Am. 2006;32(1):235–44.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Panchatcharam Parthasarathy.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Parthasarathy, P., Vivekanandan, S. Urate crystal deposition, prevention and various diagnosis techniques of GOUT arthritis disease: a comprehensive review. Health Inf Sci Syst 6, 19 (2018). https://doi.org/10.1007/s13755-018-0058-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13755-018-0058-9

Keywords

  • Gout arthritis
  • Hyperuricemia
  • Joint inflammation
  • Uric acid
  • Mono-sodium urate crystal